Franklin Resources
CMPX icon

Franklin Resources’s Compass Therapeutics CMPX Stock Holding History

Franklin Resources’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$352K Hold
66,607
– – ﹤0.01% 2601
2025
Q4 		$358K Buy
+66,607
New +$308K ﹤0.01% 2555
2025
Q2 		– Sell
-62,844
Closed -$119K – 3046
2025
Q1 		$119K Buy
+62,844
New +$167K ﹤0.01% 2792

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Franklin Resources's CMPX Position: Q1 2026 in Review

Franklin Resources held its Compass Therapeutics (CMPX) position steady in Q1 2026 at 66,607 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #2601.

Franklin Resources first reported a position in CMPX in Q1 2025 and has held it in 3 quarters since. The position peaked at $358K in Q4 2025. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Franklin Resources held 66,607 shares of Compass Therapeutics worth $352K as of Q1 2026.
  • Franklin Resources left its Compass Therapeutics share count unchanged in Q1 2026.
  • Compass Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2601 holding.
  • Franklin Resources first reported a position in Compass Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Franklin Resources's Compass Therapeutics position peaked at $358K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.